CMS Focuses on E-Prescribing


By Neil Versel, contributing editor

October 7, 2008 | BOSTON—With less than three months to go before Medicare starts paying incentives to physicians for electronic prescribing, the Centers for Medicare and Medicaid Services (CMS) is working frantically to get the word out about the benefits of such technology.

At least 1,400 people are gathering in a Boston hotel today for a whirlwind conference intended to tout the incentives and raise awareness among doctors, pharmacists, practice administrators, IT staff, vendors, and others who might have a role in e-prescribing before the program starts Jan. 1.

Acting CMS administrator Kerry Weems says Congress included “one very small but very valuable gift,” namely the e-prescribing financial incentives, buried deep in the Medicare Improvements for Patients and Providers Act that passed—over the president’s veto—in July. (See “Medicare Legislation Provides Incentives for ePrescribing.”)

The program will provide physicians with 2 percent bonus payments on top of regular Medicare fees in 2009-10, then a 1 percent bonus in 2011-12, followed by 0.5 percent in 2013. Starting in 2012, CMS will start docking providers 1 percent for failing to e-prescribe, a penalty that rises to 1.5 percent in 2013 and 2 percent in 2014. This money is in addition to the 2 percent bonuses doctors can earn for participating in the Physician Quality Reporting Initiative program.

CMS estimates that Medicare could save $156 million over the five-year life of the program through error prevention and efficiency improvements, but that figure is based on the 6 percent of physicians said to have e-prescribing systems at the end of 2007. That number now is around 8 percent and rising, according to CMS. “Our goal for this conference is to make [the savings] very different from those estimates,” Weems says.

“The key message of this conference is that you can’t qualify for the bonus if you don’t have an e-prescribing system,” says CMS chief medical officer Barry Straube.

David Brailer, the former national health-IT czar who now runs investment firm Health Evolution Partners (San Francisco) calls e-prescribing “bite-sized in terms of what physicians need to change and do,” something that help doctors make the first step toward adopting full electronic health records.

“You won’t go wrong investing your time and money,” says Brailer, whose company chose e-prescribing vendor Prematics as the recipient of one of its first investments.

“What’s the thin end of the spear? What’s the thing that really drives this into physician offices?” Brailer believes e-prescribing is the answer, and that bonus payments are the enticement. “Doctors are never sure what to focus their time on, so they do follow the money,” Brailer says.

“Our theme is accelerated adoption of this technology,” Weems says. CMS put the conference together in just six weeks, even including continuing medical education credit for physicians. “This conference is meant to jump-start that process,” Weems adds. “It’s about kicking down barriers and stepping on the accelerator for the next couple of months.”

CMS promises a final rule in November as part of the 2009 Medicare Part B fee schedule, to include a definition of “successful” e-prescribing, as well as the CPT codes which are eligible for the bonuses. “We wanted to hold the conference before [the rule comes out] to get a sense of where the industry stands,” Weems says.

“I think these Medicare incentives will go a long way in terms of overcoming some of these barriers,” says Jeffrey Smith, vice president for strategy and business development at pharmacy chain and pharmacy benefits manager CVS Caremark (Woonsocket, R.I).

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Digital End-To-End for Pharma
Sponsored by SAIC

Given the rapidly changing pharmaceutical industry landscape, traditional methods alone of identifying, retrieving, and analyzing the private and publicly available information no longer suffice. How can Pharma effectively harness the immense amounts of data from an ever-growing number of internal and external sources?

The Digital End-to-End white paper discusses some of the ways that Pharma can harness the power of the data to pursue novel products that are profitable, safe, and have proven value to one or more patient populations.



Adobe® LiveCycle® ES
Deploying Adobe Technology to Automate Electronic Submissions
Sponsored by Adobe
Discover how to:
  • Help reduce the cost of bringing products to market
  • Improve document collaboration across your organization
  • Satisfy global regulatory requirements, stockholder expectations, and customer demands
  • Improve data capture, information assurance, document output, process management, and content services
  • Gain a competitive advantage, get immediate ROI


Interoperability and Architecture for the Life Sciences Industry
What it will take to gain industry consensus on interchange standards, and what organizations can do today to optimize their own information architectures
Sponsored by SAS
Information technology is finally up to the task of cost-effective clinical research. But there are still some significant barriers to gaining all the benefits of this technology, in particular, interoperability. This white paper explores the need for a consistent industry architecture that allows life sciences firms to connect their enterprises and benefit from unified data integration, process consistency and rapid communication of meaningful drug findings.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms

Protocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now



More Podcasts

Job Openings

Manager, Scientific Computing & Programming
Lead SAIC-Frederick, Inc.’s Bioinformatics & Analysis Group in developing & maintaining informatics pipelines for generation/analysis of dense genotyping & next-generation sequencing data. Required: MS or equiv. 5 yrs related experience. Knowledge of programming/software development, high performance computing, bioinformatics, project management. Visit www.saic-frederick.com - #130019.

Related Resources & Products

Progressive Project Management Focus ®: A Strategy to Accelerate Drug Product Development
Good Clinical Practice: A Question and Answer Reference Guide 2008
Expediting Drug and Biologics Development: A Strategic Approach 2006



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].